>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Novo A Buys Praxis Precision Medicines Inc, Aligos Therapeutics Inc, Eargo Inc, Sells Vanguard Total Stock Market ETF, Medtronic PLC, Catalent Inc

Investment company Novo A (Current Portfolio) buys Praxis Precision Medicines Inc, Aligos Therapeutics Inc, Eargo Inc, Galecto Inc, Freeline Therapeutics Holdings PLC, sells Vanguard Total Stock Market ETF, Medtronic PLC, Catalent Inc, SI-BONE Inc, Vaxcyte Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Novo A. As of 2020Q4, Novo A owns 43 stocks with a total value of $2.2 billion. These are the details of the buys and sells.

For the details of Novo A's stock buys and sells, go to https://www.gurufocus.com/guru/novo+a/current-portfolio/portfolio

These are the top 5 holdings of Novo A
  1. Vanguard Total Stock Market ETF (VTI) - 1,933,900 shares, 17.11% of the total portfolio. Shares reduced by 37.01%
  2. Nkarta Inc (NKTX) - 2,793,864 shares, 7.81% of the total portfolio.
  3. Inogen Inc (INGN) - 3,549,320 shares, 7.21% of the total portfolio.
  4. Apple Inc (AAPL) - 1,037,404 shares, 6.26% of the total portfolio. Shares reduced by 17.15%
  5. Praxis Precision Medicines Inc (PRAX) - 2,442,080 shares, 6.11% of the total portfolio. New Position
New Purchase: Praxis Precision Medicines Inc (PRAX)

Novo A initiated holding in Praxis Precision Medicines Inc. The purchase prices were between $27.25 and $55.82, with an estimated average price of $38.91. The stock is now traded at around $35.560000. The impact to a portfolio due to this purchase was 6.11%. The holding were 2,442,080 shares as of 2020-12-31.

New Purchase: Aligos Therapeutics Inc (ALGS)

Novo A initiated holding in Aligos Therapeutics Inc. The purchase prices were between $13.2 and $32.74, with an estimated average price of $19.48. The stock is now traded at around $24.140000. The impact to a portfolio due to this purchase was 3.29%. The holding were 2,614,563 shares as of 2020-12-31.

New Purchase: Eargo Inc (EAR)

Novo A initiated holding in Eargo Inc. The purchase prices were between $33.49 and $57.94, with an estimated average price of $42.12. The stock is now traded at around $55.750000. The impact to a portfolio due to this purchase was 1.5%. The holding were 737,071 shares as of 2020-12-31.

New Purchase: Galecto Inc (GLTO)

Novo A initiated holding in Galecto Inc. The purchase prices were between $12.51 and $16.84, with an estimated average price of $14.88. The stock is now traded at around $10.120000. The impact to a portfolio due to this purchase was 1.42%. The holding were 2,497,791 shares as of 2020-12-31.

New Purchase: Pulmonx Corp (LUNG)

Novo A initiated holding in Pulmonx Corp. The purchase prices were between $41.35 and $69.02, with an estimated average price of $49.13. The stock is now traded at around $57.700000. The impact to a portfolio due to this purchase was 0.59%. The holding were 187,047 shares as of 2020-12-31.

New Purchase: F-star Therapeutics Inc (FSTX)

Novo A initiated holding in F-star Therapeutics Inc. The purchase prices were between $4.06 and $10.39, with an estimated average price of $8.53. The stock is now traded at around $8.680000. The impact to a portfolio due to this purchase was 0.02%. The holding were 34,819 shares as of 2020-12-31.

Added: Freeline Therapeutics Holdings PLC (FRLN)

Novo A added to a holding in Freeline Therapeutics Holdings PLC by 255.07%. The purchase prices were between $14.94 and $18.3, with an estimated average price of $16.78. The stock is now traded at around $14.560000. The impact to a portfolio due to this purchase was 1.41%. The holding were 2,361,229 shares as of 2020-12-31.

Added: Verona Pharma PLC (VRNA)

Novo A added to a holding in Verona Pharma PLC by 44.87%. The purchase prices were between $5.51 and $8.11, with an estimated average price of $6.76. The stock is now traded at around $8.880000. The impact to a portfolio due to this purchase was 0.26%. The holding were 2,608,755 shares as of 2020-12-31.

Added: Milestone Pharmaceuticals Inc (MIST)

Novo A added to a holding in Milestone Pharmaceuticals Inc by 21.63%. The purchase prices were between $5.57 and $7.66, with an estimated average price of $6.69. The stock is now traded at around $6.590000. The impact to a portfolio due to this purchase was 0.14%. The holding were 2,530,585 shares as of 2020-12-31.

Sold Out: Medtronic PLC (MDT)

Novo A sold out a holding in Medtronic PLC. The sale prices were between $100.57 and $117.14, with an estimated average price of $110.21.

Sold Out: SI-BONE Inc (SIBN)

Novo A sold out a holding in SI-BONE Inc. The sale prices were between $20.44 and $30.88, with an estimated average price of $24.36.

Sold Out: CureVac NV (CVAC)

Novo A sold out a holding in CureVac NV. The sale prices were between $46.76 and $136.27, with an estimated average price of $77.02.

Sold Out: Akebia Therapeutics Inc (AKBA)

Novo A sold out a holding in Akebia Therapeutics Inc. The sale prices were between $2.22 and $3.78, with an estimated average price of $2.93.

Sold Out: Entasis Therapeutics Holdings Inc (ETTX)

Novo A sold out a holding in Entasis Therapeutics Holdings Inc. The sale prices were between $1.61 and $2.85, with an estimated average price of $1.96.

Reduced: Vanguard Total Stock Market ETF (VTI)

Novo A reduced to a holding in Vanguard Total Stock Market ETF by 37.01%. The sale prices were between $166.99 and $194.64, with an estimated average price of $183.18. The stock is now traded at around $200.360000. The impact to a portfolio due to this sale was -9.61%. Novo A still held 1,933,900 shares as of 2020-12-31.

Reduced: Catalent Inc (CTLT)

Novo A reduced to a holding in Catalent Inc by 38.66%. The sale prices were between $85.88 and $105.36, with an estimated average price of $97.08. The stock is now traded at around $108.370000. The impact to a portfolio due to this sale was -2.67%. Novo A still held 997,349 shares as of 2020-12-31.

Reduced: Vaxcyte Inc (PCVX)

Novo A reduced to a holding in Vaxcyte Inc by 35.98%. The sale prices were between $26.57 and $51.74, with an estimated average price of $37.01. The stock is now traded at around $25.830000. The impact to a portfolio due to this sale was -0.58%. Novo A still held 416,937 shares as of 2020-12-31.

Reduced: Amicus Therapeutics Inc (FOLD)

Novo A reduced to a holding in Amicus Therapeutics Inc by 27.38%. The sale prices were between $13.47 and $24.89, with an estimated average price of $20.55. The stock is now traded at around $10.660000. The impact to a portfolio due to this sale was -0.45%. Novo A still held 1,684,795 shares as of 2020-12-31.

Reduced: SeaSpine Holdings Corp (SPNE)

Novo A reduced to a holding in SeaSpine Holdings Corp by 20.17%. The sale prices were between $12.76 and $18.33, with an estimated average price of $15.24. The stock is now traded at around $18.170000. The impact to a portfolio due to this sale was -0.24%. Novo A still held 1,339,085 shares as of 2020-12-31.

Reduced: Spero Therapeutics Inc (SPRO)

Novo A reduced to a holding in Spero Therapeutics Inc by 38.06%. The sale prices were between $12.06 and $22.07, with an estimated average price of $15.65. The stock is now traded at around $17.320000. The impact to a portfolio due to this sale was -0.2%. Novo A still held 576,702 shares as of 2020-12-31.



Here is the complete portfolio of Novo A. Also check out:

1. Novo A's Undervalued Stocks
2. Novo A's Top Growth Companies, and
3. Novo A's High Yield stocks
4. Stocks that Novo A keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)